Samalin Investment Counsel’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Samalin Investment Counsel's MDT Position: Q2 2023 in Review
Samalin Investment Counsel sold out of Medtronic (MDT) in Q2 2023, closing a stake of 3,618 shares — an estimated $292K sold.
Samalin Investment Counsel first reported a position in MDT in Q4 2019 and held it in 14 quarters. The position peaked at $423K in Q1 2022. 2,057 funds tracked by Wall St. Rank hold MDT as of Q2 2023.
- Samalin Investment Counsel reported no remaining Medtronic position as of Q2 2023 after selling out during the quarter.
- Samalin Investment Counsel sold 3,618 Medtronic shares in Q2 2023, an estimated $292K.
- Samalin Investment Counsel first reported a position in Medtronic in Q4 2019 and held it in 14 quarters.
- Samalin Investment Counsel's Medtronic position peaked at $423K in Q1 2022.
- 2,057 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.
Based on Samalin Investment Counsel's 13F filing for Q2 2023, filed 3 Aug 2023.